Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 91,917 | 107,639 | 99,664 | 50,350 | 51,485 |
| Marketable Securities | 19,984 | 42,106 | 79,721 | 74,483 | 95,812 |
| Receivables | 2 | 12 | 27 | 18 | 35 |
| Other current assets | 1,726 | 2,446 | 3,536 | 3,329 | 3,263 |
| TOTAL | $113,629 | $152,203 | $182,948 | $128,180 | $150,595 |
| Non-Current Assets | |||||
| PPE Net | 79,434 | 80,672 | 82,598 | 84,631 | 86,524 |
| Investments And Advances | 21,593 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 11,014 | 11,009 | 11,108 | 104,687 | 104,745 |
| TOTAL | $112,041 | $91,681 | $93,706 | $189,318 | $191,269 |
| Total Assets | $225,670 | $243,884 | $276,654 | $317,498 | $341,864 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 601 | 1,025 | 1,486 | 2,691 | 3,271 |
| Accounts payable and accrued liabilities | 2,739 | 1,408 | 3,776 | 17,294 | 15,663 |
| Accrued Expenses | 13,235 | 12,620 | 21,717 | N/A | N/A |
| TOTAL | $19,494 | $17,972 | $29,907 | $20,021 | $18,943 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 47,438 | 47,933 |
| Deferred Revenues | 2,919 | 2,919 | 2,928 | 36 | 9 |
| Other Non-Current Liabilities | 4,455 | 4,636 | 4,710 | 5,085 | 5,939 |
| TOTAL | $126,335 | $127,246 | $128,050 | $52,523 | $53,872 |
| Total Liabilities | $145,829 | $145,218 | $157,957 | $72,544 | $72,815 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 38,438 | 38,421 | 38,274 | 37,997 | 37,990 |
| Common Shares | 38 | 38 | 38 | 38 | 38 |
| Retained earnings | -656,698 | -635,727 | -614,650 | -486,675 | -459,435 |
| Other shareholders' equity | -1,510 | -1,376 | -233 | 1,205 | 634 |
| TOTAL | $79,841 | $98,666 | $118,697 | $244,954 | $269,049 |
| Total Liabilities And Equity | $225,670 | $243,884 | $276,654 | $317,498 | $341,864 |